• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Enrofloxacin     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : umbel-rc:DrugProduct, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)

Type: Thingdul:ChemicalObjectchemical substanceDrugyago:WikicatAntibioticsyago:WikicatCyclopropanesyago:WikicatVeterinaryDrugsyago:Agent114778436yago:Anesthetic102710766yago:Antibacterial102716205yago:Antibiotic102716866yago:CausalAgent100007347yago:Cyclopropane103155661yago:Drug103247620yago:GeneralAnesthetic103433434yago:InhalationAnesthetic103570838yago:Matter100020827yago:Medicine103740161yago:PhysicalEntity100001930yago:Piperazine103946814drugyago:Substance100020090yago:Vermifuge104528630yago:WikicatDrugsyago:WikicatFluoroquinoloneAntibioticsyago:WikicatPiperazinesyago:WikicatQuinoloneAntibioticsumbel-rc:DrugProduct New Facet based on Instances of this Class

Enrofloxacin (ENR) is a fluoroquinolone antibiotic sold by the Bayer Corporation under the trade name Baytril. It is sold by in a generic form by Bimeda Inc. under the name EnroMed 100. Enrofloxacin is currently approved by the FDA for the treatment of individual pets and domestic animals in the United States. In September 2005, the FDA withdrew approval of Baytril for use in water to treat flocks of poultry, as this practice was noted to promote the evolution of fluoroquinolone-resistant strains of the bacterium Campylobacter, a human pathogen.